Fierce Health Payers November 11, 2021
Heather Landi

As it builds more evidence to support its virtual reality therapeutic for managing pain, startup AppliedVR picked up $36 million in fresh funding to fuel its growth.

The Los Angeles-based company also is awaiting a decision from the Food and Drug Administration (FDA) on its first de novo submission. The company is preparing for full market launch of its flagship product, EaseVRx, after FDA approval.

With this funding, AppliedVR also has its sights set on additional payer pilots, building out its product pipeline, conducting more clinical research and continuing to build its VR pharmacy platform, executives said.

The series B funding included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures. The company has raised $71 million...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Metaverse/VR, Technology, Trends
Apple to launch Vision Pro in China this year, Tim Cook says
Apple CEO Says Vision Pro Coming to China This Year
Explained: Life in the Metaverse
Nvidia enables high-res Omniverse Cloud imagery on Apple Vision Pro
Future medicine makers will get VR training at new UK centre

Share This Article